April 18, 2018 – Xenex Disinfection Services, the market leader in ultraviolet (UV) room disinfection technology, today announced it has expanded its relationship with Terumo Corporation, one of the world’s leading medical device manufacturers and distributors, and Terumo is now the exclusive distributor of Xenex® LightStrike™ Germ-Zapping Robots™ in Singapore as well as Japan.
Healthcare Associated Infections (HAIs) caused by pathogens such as Methicillin-resistant Staphylococcus aureus (MRSA), Acinetobacter and carbapenem-resistant Enterobacteriaceae (CRE) are a global problem. Xenex’s pulsed xenon UV room disinfection technology is a proven solution that destroys these deadly microorganisms before they can pose a threat to patients and healthcare workers.
“We carefully evaluated the various technologies that are being used to combat HAIs and chose Xenex, because they offer an environmentally-friendly and evidence-based UV technology that has been shown to reduce hospital infection rates in multiple peer-reviewed published outcome studies. Based on the success we’ve seen with the LightStrike technology in Japan, we are expanding the relationship to provide LightStrike robots to public and private healthcare facilities in Singapore,” said Tsuyoshi Tomita, Group Manager, General Hospital Products Group, Hospital Systems Division, General Hospital Company at Terumo Corporation.
Xenex robots help hospitals enhance patient safety by destroying the microscopic germs that may be missed during the manual cleaning process. Xenex’s germ fighting robots take room decontamination to the next level by using pulsed xenon, an environmentally-friendly noble gas, to create high intensity UV light that quickly destroys infectious germs. Hospitals using LightStrike robots have published outcome studies in peer-reviewed journals showing 50-100 percent decreases in Clostridium difficile, MRSA and Surgical Site Infection rates when those hospitals used the Xenex robots to disinfect rooms.
“We are honored to work alongside Terumo to bring our room disinfection technology to Singapore, which has a highly advanced medical system and is well known as a medical tourism hub. A recent study published in Clinical Infectious Diseases about the prevalence of HAIs indicated that infections are an issue for Singapore hospitals, and we are confident that our Germ-Zapping Robots can greatly assist these facilities in reducing their HAI rates. Hospitals working with Terumo will now be able to provide patients with a cleaner environment during their hospital stay, which will greatly enhance the patient experience,” said Vanessa Crum, vice president of international sales for Xenex.
Xenex Disinfection Services
Xenex’s patented Full SpectrumTM pulsed xenon UV room disinfection system is used for the advanced disinfection of healthcare facilities. Due to its speed and ease of use, the Xenex system has proven to integrate smoothly into hospital cleaning operations. Xenex’s mission is to save lives and reduce suffering by destroying the deadly microorganisms that cause hospital acquired infections (HAIs). The company is backed by well-known investors that include Malin Corporation, Battery Ventures, Targeted Technology Fund II, Tectonic Ventures and RK Ventures. For more information, visit Xenex.com.
About Terumo Corporation
Tokyo-based Terumo Corporation is one of the world’s leading medical device manufacturers with over $5 billion in sales and operations in more than 160 nations. Founded in 1921, the company develops, manufactures and distributes world-class medical devices including products for use in cardiothoracic surgery, interventional procedures and transfusion medicine; the company also manufactures a broad array of syringe and hypodermic needle products for hospital and physician office use. Terumo contributes to society by providing valued products and services to the health care market and by responding to the needs of health care providers and the people they serve. Terumo Corporation’s shares are listed on the first section of the Tokyo Stock Exchange (No. 4543, Reuters symbol <4543.T>, or Bloomberg 4543: JP) and is a component of the Nikkei 225, Japan’s leading stock index.